Effects of Traditional Chinese Medicine Adjuvant Therapy on the Survival of Patients with Primary Liver Cancer

Figure 3

The 3-year overall survival rate of patients with primary liver cancer in different subgroups after propensity score matching. (a) BCLC staging A. (b) BCLC staging B–D. (c) Compensation period. (d) Decompensation period. (e) Child–Pugh class A. (f) Child–Pugh class B. (g) Child–Pugh class C. (h) AFP (ng/ml) ˂400. (i) AFP (ng/ml) ≥400. (j) Noncirrhosis. (k) Liver cirrhosis.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)